Lv4
540 积分 2021-04-30 加入
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
15天前
已完结
Review for "Hydrophobic interaction-driven binding of ensifentrine stabilizes PDE3A: insights from X-ray crystallography and molecular dynamics"
1个月前
已完结
Polymorphism, phase transition, and physicochemical property investigation of Ensifentrine
2个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches
2个月前
已完结
The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals
2个月前
已关闭
Ensifentrine: First Approval
2个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
2个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
2个月前
已完结
皖公网安备34019202002308
